Chan Thomas (Tc) Buys Shares of GDRX $GDRX

Key Points

  • Chan Thomas (Tc) bought 4,069 shares of GoodRx Holdings, Inc. ($GDRX).
  • $GDRX last traded around $2.65.

Chan Thomas (Tc), Chief Accounting Officer at GoodRx Holdings, Inc. ($GDRX), bought 4,069 shares. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.

GoodRx Holdings, Inc. ($GDRX) Stock

Last price$2.65
Market cap$924.58M
P/E ratio45.50
Forward P/E7.62
Beta1.61
52-week low$1.77
52-week high$5.81
50-day MA$2.53
200-day MA$2.90
Current ratio1.47
Quick ratio0.56
Debt-to-equity0.87

GoodRx Holdings, Inc. Earnings

EPS (ttm)$0.06
Revenue (ttm)$787.89M
Revenue growth-4.4%
Net margin2.6%
Return on equity3.2%
Next earningsAug 5, 2026

Analysts Set New Price Targets

ConsensusHold
Average target$3.18
High target$4.00
Low target$2.25
Analysts covering13

About GoodRx Holdings, Inc.

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.

ExchangeNasdaqGS
SectorHealthcare
IndustryHealth Information Services
HeadquartersSanta Monica, CA
CEOMs. Wendy Barnes
Employees697

See Also

This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.